N ‐terminal B‐type natriuretic peptide (NT‐proBNP) is associated with disease severity in multiple myeloma
ConclusionsElevated levels of the cardiovascular marker NT‐proBNP are associated with disease severity in patients with MM.This article is protected by copyright. All rights reserved.
Source: European Journal of Clinical Investigation - Category: General Medicine Authors: Noemi Pavo, Anna Cho, Raphael Wurm, Guido Strunk, Maria Krauth, Hermine Agis, Martin H ülsmann Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | General Medicine | Heart | Laboratory Medicine | Myeloma | Study